Botulinum Toxin A Merz - Biotech, Pharma and Life Science Channel

14:02 EST 21st November 2014 | BioPortfolio

PubMed Articles [669 Associated PubMed Articles listed on BioPortfolio]

CYN determination in tissues from freshwater fish by LC-MS/MS: Validation and application in tissues from subchronically exposed tilapia (Oreochromis niloticus).

Harmful cyanobacterial blooms are occurring in eutrophic freshwater lakes and reservoirs throughout the world and, because of the production of toxins such as cylindrospermopsin (CYN), they can presen...

Enhanced detection of the algal toxin PbTx-2 in marine waters by atmospheric pressure chemical ionization mass spectrometry.

Karenia brevis, a marine dinoflagellate, biosynthesizes a unique class of polyether toxins called brevetoxins that produce significant health, environmental and economic impacts in and along coastal w...

Prevalence of Escherichia coli O157:H7 in Surface Water Near Cattle Feedlots.

Abstract Between April 2009 and July 2011, 311 surface water samples in 48 cattle feedlots distributed in an area of about 67,000 km(2) were analyzed to examine the environmental dissemination of Es...

Descriptive Epidemiology of Nasal Carriage of Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus Among Patients Admitted to Two Healthcare Facilities in Algeria.

Aim: To evaluate nasal carriage rate and variables associated with Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted in two healthcare facilities. Resul...

Crystal structure of Bacillus anthracis virulence regulator AtxA and effects of phosphorylated histidines on multimerization and activity.

The Bacillus anthracis virulence regulator AtxA controls transcription of the anthrax toxin genes and capsule biosynthesis operon. AtxA activity is elevated during growth in media containing glucose a...

Suppression of Starvation-Induced Autophagy by Recombinant Toxic Shock Syndrome Toxin-1 in Epithelial Cells.

Toxic shock syndrome toxin-1 (TSST-1), a superantigen produced from Staphylococcus aureus, has been reported to bind directly to unknown receptor(s) and penetrate into non-immune cells but its functio...

T-2 and HT-2 toxins in oat flakes: development of a certified reference material.

Trichothecene mycotoxins, with T-2 and HT-2 toxins being the main representatives of the type A subgroup, are naturally and worldwide occurring contaminants frequently found in grain-based food and fe...

The Arabidopsis PLAT Domain Protein1 Is Critically Involved in Abiotic Stress Tolerance.

Despite the completion of the Arabidopsis genome sequence, for only a relatively low percentage of the encoded proteins experimental evidence concerning their function is available. Plant proteins tha...

Simultaneous determination of multi-mycotoxins in palm kernel cake (PKC) using liquid chromatography tandem mass spectrometry (LC-MS/MS).

Palm kernel cake (PKC) is a useful source of protein and energy for livestock. Recently PKC has been used as an ingredient in poultry feed. Mycotoxin contamination of PKC due to inappropriate handling...

Cytotoxic Mechanism of Cytolethal Distending Toxin in Nontyphoidal Salmonella Serovar (Salmonella Javiana) During Macrophage Infection.

Cytolethal distending toxin B (cdtB) is a conserved virulence factor in Salmonella enterica serovar Typhi. Here we report the presence and functionality of cdtB in some nontyphoidal Salmonella (NTS) s...

News Articles [205 Associated News Articles listed on BioPortfolio]

Hookahs deliver toxic benzene in every puff, study shows

(HealthDay)—Many young people consider hookahs a hip and safer way to smoke, but a new study finds fumes from the water pipes contain the toxin benzene.

PharmAthene Fulfills Valortim® IDIQ Contract

ANNAPOLIS, Md., Nov. 20, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announc...

Carbohydrate Found in Pistachio Nuts, Other Foods Impairs Athletic Performance

A recent study by David Nieman, DrPH, director of the Appalachian State University Human Performance Laboratory at the N.C. Research Campus (NCRC) in Kannapolis, found that a spec...

Biochemists Build Largest Synthetic Molecular "Cage" Ever

Brett Smith for redOrbit.com - Your Universe Online Biochemists at UCLA have been working to develop a ‘cage-like’ structure made of proteins to deliver materials into cells, and on Monday, the...

Jim Greenwood Op-Ed: Time to Fund Medical Countermeasures against Threats like Ebola

On Friday, The Hill published an op-ed from BIO President and CEO Jim Greenwood calling on Congressional appropriators to fully fund federal biodefense programs, which partner with industry to develop...

Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance

Mark Walker and colleagues report the whole-genome sequencing of 132 group A Streptococcus (GAS) isolates of a sequence type that has been associated with scarlet fever. The isolates were obtained fro...

All Natural Liver Detox and Cleanse Formula Set To Shake Up The Supplement Industry

COVENTRY, R.I., Nov. 18, 2014 /PRNewswire/ -- Would you use a gasoline filled fire extinguisher to put out a fire?  This is the question Perfect Supplements, LLC is asking consumers when the...

Merz Pharmaceuticals GmbH - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Merz Pharmaceuticals GmbH - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-11-13. This 24-page report is ...

Merz Pharma Canada Announces Exclusive Distribution Arrangement with Ulthera

Merz Pharma Canada, Ltd., affiliate of the global Merz Pharma Group, today announced that it has signed an agreement with Ulthera, Inc. which grants Merz exclusive rights for the ...

Anterios, Inc. Hires Fabian Tenenbaum As Chief Financial Officer And Chief Business Officer

NEW YORK, Nov. 17, 2014 /PRNewswire/ -- Anterios, Inc., a privately held medical dermatology and aesthetic medicine biopharmaceutical company, announced today that it has hired Fabian Tenenbaum to ser...

Events [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Merz North America, Inc.

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in medical and aesthetic dermatology, and neurology in the U.S...

Merz North America

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurology in the U.S. and Canad...

Merz, Inc.

Merz, Inc. is a focused specialty healthcare company that is responsible for developing and commercializing innovative products and solutions in neurology, medical aesthetics, and...

Pharmaleads

Pharmaleads is a research company focussed on the custom design of substrates and inhibitors of zinc metallopeptidases and proteases. Pharmaleads has already developed molecules for ECE, NEP, ACE, APN...

Molecular Templates

Molecular Templates is a biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics using its novel Engineered Toxin Bodies (ETB) platfor...

Merz Aesthetics

Merz Aesthetics, the new business unit of Merz Pharma Group, is a leader in the global aesthetic medicine market. With a 100-year history of compassion and innovation in healthcare, Merz Aesthetics i...

DentaSpa

DentaSpa™ is one of the nation’s leading Botulinum Toxin, dermal fillers and injectables business education companies tailored exclusively for dental practitioners. Dent...

Clinical Trials [209 Associated Clinical Trials listed on BioPortfolio]

Botox Injection in Treatment of Chronic Migraine

Chronic migraine is in many cases a most disabling condition. Chronic migraine is defined as headaches for at least 15 days per month, of which 8 days have typical migraine features. In ma...

BOTOX® Treatment in Pediatric Upper Limb Spasticity

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) in pediatric patients with upper limb spasticity.

BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric upper limb spasticity.

Study of Botulinum Toxin and Recovery of Hand Function After Stroke

The purpose of this study is to determine whether injections of botulinum toxin (commonly known as BOTOX®) into the affected hand of Stroke patients, while targeting the muscles controlli...

Pain Perception of Children and Youth Receiving Non-sedated Botulinum Toxin-A Injections Using the Buzzy®

The use of Botulinum toxin injections (BoNT-A) has become a standard therapy for children and youth who suffer from stiffness of their muscles due to a neurological problem. These injectio...

Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy

The purpose of this study is to determine whether injections of Botulinum toxin type A into muscles of one or both arms alone or in combination with injections into one or both legs are ef...

A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)

MK-3415A is the combination of monoclonal antibodies to Clostridium (C.) difficile toxin A (MK-3415) and toxin B (MK-6072). This study will investigate whether: 1) treatment with MK-6072 o...

Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study

The objective of the study is to compare the time to onset of Dysport® versus Botox® in the treatment of lateral orbital rhytids ("crow's feet"). Thirty subjects were enrolled in the stu...

The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction

Breast reconstruction is a common procedure with over 86,000 breast reconstruction procedures performed in the United States in 2009. This is a 1.5-fold increase since 2007. Of these breas...

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

The purpose of this study is to assess the long term safety and effectiveness of botulinum toxin type A in treating patients with idiopathic overactive bladder with urinary incontinence.

Medical and Biotech [MESH] Definitions

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type C which is neurotoxic to ANIMALS, especially CATTLE, but not humans. It causes dissociation of ACTIN FILAMENTS.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type D which is neurotoxic to ANIMALS, especially CATTLE, but not humans.

Subtype of CLOSTRIDIUM BOTULINUM that produces BOTULINUM TOXIN TYPE A which is neurotoxic to humans and animals.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type B which is neurotoxic to humans and animals.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type E which is neurotoxic to humans and animals.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Botulinum Toxin A Merz market research data and corporate reports here

Channels Quicklinks